Nature Reviews Disease Primers
ISSN 2056-676x · Nature Portfolio · United Kingdom · active 1985–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Is this the right journal for your paper?
The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.
Indexing & access
Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Nature Reviews Disease Primers a predatory journal?
Our screening does not flag Nature Reviews Disease Primers. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Nature Reviews Disease Primers indexed in Scopus or Web of Science?
Per our venue index, Nature Reviews Disease Primers appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is the impact factor of Nature Reviews Disease Primers?
Papers in Nature Reviews Disease Primers are cited about 33.0 times each within two years of publication, and Scimago places it in Q1, with an h-index of 272. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.
What Scimago quartile is Nature Reviews Disease Primers (Q1, Q2, Q3, or Q4)?
Scimago places Nature Reviews Disease Primers in Q1 for its subject category. Quartiles split the journals in a field into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; Nature Reviews Disease Primers is cited about 33.0 times per paper over two years, with an h-index of 272. A journal is ranked per subject category, so one spanning several fields can sit in different quartiles depending on the category.
What is the Web of Science (JCR) quartile of Nature Reviews Disease Primers?
The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for Nature Reviews Disease Primers. The open equivalent is its Scimago quartile, Q1, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.
Is Nature Reviews Disease Primers open access?
We hold no reliable open-access classification for Nature Reviews Disease Primers. Check the journal's own site for its access model and any article processing charge.
Ready to submit? Tools for your next paper
Similar venues
- Nature Reviews RheumatologyQ1 · Nature Portfolio
- American Journal of Clinical DermatologyQ1 · Adis, Springer Healthcare
- The Lancet RheumatologyQ1 · Elsevier BV
- Neurology Neuroimmunology & NeuroinflammationQ1 · Wolters Kluwer
- Current Rheumatology ReportsQ1 · Springer Science+Business Media
- Best Practice & Research Clinical RheumatologyQ1 · Elsevier BV